
Merck & Co., Inc. (NYSE:MRK) Presents Immunotherapy Findings; Collaborates With Ferring And WHO
Boston, MA 04/07/2014 (wallstreetpr) – Yesterday, Merck & Co., Inc. (NYSE:MRK) provided early discoveries associated with the relation between PD-L1 Expression and the clinical outcome of













